Approval · Notice of Compliance 30251 · 2023
OPTIGRID: Notice of Compliance 30251
Issued March 6, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30251
- Date
- March 6, 2023
- Company
- Huvepharma EoodSofia, Sofia, Bulgaria
- Product type
- Veterinary
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- OPTAFLEXX 100 (Elanco Canada Limited)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OPTIGRID | 02535823 | Approved |
Medicinal ingredients
- RACTOPAMINE HCL 100 G per KG